Wikipedia:Articles for deletion/Sangamo BioSciences
or perhaps redirect to Zinc finger nuclease#Prospects. I was unable to find more than brief mentions of the company in reliable sources, so it seems to fail notability thresholds per . Perhaps the most notable thing about the company is their SB-728-T clinical trial, which was discussed in reliable sources like a http://www.nytimes.com/2009/12/29/health/research/29zinc.html New York Times article and a http://www.scientificamerican.com/article/new-aids-treatment-immune-cell-genes/ Scientific American article. These independent RS suggest that a mention of the trial at WP is reasonable and indeed it is already at Zinc finger nuclease#Prospects in the last sentence. I'd be OK with a redirect to that section, but because it isn't a perfect target, delete is a reasonable option too
— User:Mark, 18:08, 29 May 2016 (UTC)
Stance: delete
Cited policy: WP:GNG (Wikipedia:Notability)